I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| B cell | 6 studies | 20% ± 5% | |
| plasmablast | 5 studies | 29% ± 13% | |
| natural killer cell | 5 studies | 32% ± 10% | |
| deuterosomal cell | 4 studies | 35% ± 8% | |
| hematopoietic precursor cell | 4 studies | 23% ± 4% | |
| epithelial cell | 4 studies | 25% ± 9% | |
| CD8-positive, alpha-beta T cell | 4 studies | 25% ± 6% | |
| T cell | 3 studies | 23% ± 2% | |
| abnormal cell | 3 studies | 26% ± 9% | |
| neural crest cell | 3 studies | 26% ± 7% | |
| granulocyte monocyte progenitor cell | 3 studies | 23% ± 5% | |
| transit amplifying cell | 3 studies | 45% ± 18% |
